8-K
filed February 6, 2026, 6:59 PM ET
ticker VTAK
CIK 0001716621
M&A
confidence high
sentiment neutral
materiality 0.85
Catheter Precision raises $2.18M in private placement, acquires 19.98% stake in FLYTE for $5.25M
Catheter Precision, Inc.
- Initial closing of private placement yields $2.18M; additional closings could raise up to ~$44.6M total.
- Issues Series C-1 convertible preferred at $1.43/share; conversion price can reset to 80% of market price after stockholder approval.
- Acquires 19.98% of Fly Flyte, Inc. (air-mobility) for $5.25M in Series D convertible preferred, contingent on stockholder approval.
- Existing Series B preferred and warrants repriced to $1.78, generating $400k cash from warrant exercises.
- Proceeds to repay debt, wind down legacy catheter business, and explore going-private or spin-off transactions.
Key facts
Extracted from this filing and checked against the source text.
Equity Issuances
SEC 8-K Item 3.02/3.03
confidence 0.9
Catheter Precision, Inc. issued 392,608 shares of common stock to certain accredited investors for $1.43 per share.
- Security
- common stock
- Shares
- 392,608 shares
- Purchaser
- certain accredited investors
- Consideration
- $1.43 per share
Exact text from the filing
Placement Financing”) of an aggregate of (i) 392,608 shares of the Company’s common stock, par value $0.0001 per share (“Common Stock”), at a per share purchase price of $1.43 (the “Common Shares”) and (ii) 1,616.33 shares newly-designated Series C-1 Convertible Preferred Stock, with a par value of $0.0001 per share and a stated value of $1,000 per
View on SEC.gov
Equity Issuances
SEC 8-K Item 3.02/3.03
confidence 0.9
Catheter Precision, Inc. issued 1,616.33 shares newly-designated Series C-1 Convertible Preferred Stock of preferred stock to certain accredited investors for stated value of $1,000 per share.
- Security
- preferred stock
- Shares
- 1,616.33 shares newly-designated Series C-1 Convertible Preferred Stock
- Purchaser
- certain accredited investors
- Consideration
- stated value of $1,000 per share
Exact text from the filing
of $1.43 (the “Common Shares”) and (ii) 1,616.33 shares newly-designated Series C-1 Convertible Preferred Stock, with a par value of $0.0001 per share and a stated value of $1,000 per share, initially convertible into up to 1,130,301shares of Common Stock, at an initial conversion price of $1.43 per share (the “Series C-1 Preferred Stock” and, together with
View on SEC.gov
Governance Changes
SEC 8-K Item 5.03/5.05/5.06
confidence 0.4
Catheter Precision, Inc.: Filing of Certificate of Designations for Series C-1 Preferred Stock, referenced as a charter amendment under Item 5.03.
- Change
- fiscal year change
Exact text from the filing
Item 5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year. The information contained in Item 1.01 of this Current Report on Form 8-K is incorporated herein by reference.
View on SEC.gov
Material Agreements
SEC 8-K Item 1.01/1.02
confidence 0.9
Catheter Precision, Inc. entered into Financing Purchase Agreement with certain accredited investors valued at $2,177,759.00 (effective 2026-02-06).
- Action
- entry
- Agreement
- equity purchase
- Counterparty
- certain accredited investors
- Value
- $2,177,759.00
- Effective
- 2026-02-06
Exact text from the filing
On February 6, 2026, Catheter Precision, Inc. (the “Company”) entered into a securities purchase agreement (the “Financing Purchase Agreement”) with certain accredited investors (collectively, the “Purchasers”) for the issuance and sale in a private placement (the “Private Placement Financing”) of an aggregate of (i) 392,608 shares of the Company’s common stock, par value $0.0001 per share (“Common Stock”), at a per share purchase price of $1.43 (the “Common Shares”) and (ii) 1,616.33 shares newly-designated Series C-1 Convertible Preferred Stock, with a par value of $0.0001 per share and a stated value of $1,000 per share, initially convertible into up to 1,130,301shares of Common Stock, at an initial conversion price of $1.43 per share (the “Series C-1 Preferred Stock” and, together with the Common Shares, the “Initial Securities”), for an aggregate purchase price of $2,177,759.00 with respect to the Initial Securities
View on SEC.gov
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.